What Caught Our Attention: In a letter to the editor, researchers led by Mark Bolland recently outlined the many reasons why a study by Yoshihiro Sato and colleagues in The American Journal of Medicine was “unreliable,” including evidence that the patient numbers were not achievable as described, and inconsistencies and errors in the study data. And let’s not forget a 2016 analysis (co-authored by Bolland) which cast doubt on Sato’s body of work, suggesting that more than 30 of his papers could be problematic. Continue reading Caught Our Notice: No retraction for “likely fraudulent” study
Earlier this month, we reported on the unexplained withdrawal of a case report from the American Journal of Medicine whose authors said they had treated a man in St. Louis who used krokodil, a homemade mixture of prescription painkillers
heroin and flammable contaminants that has proven deadly in Russia.
At the time, all the journal’s publisher, Elsevier, would say about why the article was removed was that there was “a permission problem that the originating institution is working to resolve.”
The paper has now reappeared. And contrary to the notice that appeared on the withdrawal Continue reading St. Louis Krokodil paper reappears
On November 11, St. Louis’s KTVI reported that krokodil, a nasty opioid concoction with roots in Russia, had arrived in their town. They based that report on a case study published in the American Journal of Medicine, “Krokodil’—A Designer Drug From Across the Atlantic, with Serious Consequences,” and interviewed two of the paper’s authors, Dany Thekkemuriyil and Unnikrishnan Pillai.
The case study involved a 30-year-old man the Thekkemuriyil and Pillai said they had seen at St. Mary’s Health Center in Richmond Heights, Missouri. As the St. Louis Post-Dispatch reported a few days later: Continue reading Drug withdrawal: St. Louis Krokodil paper disappears